Biotechs year in review

What’s Happening

Here’s the thing: Is the biotech industry truly out of its slump?

This week on “The Readout LOUD,” a biotech year in review and a look ahead to next year’s trends. (we’re not making this up)

The Readout LOUD The Readout LOUD The future of American science and a dispatch from ASH By Allison DeAngelis , Adam Feuerstein , and Elaine Chen The Readout LOUD The Readout LOUD A new top drug regulator and the future of psychedelics By Elaine Chen , Adam Feuerstein , and Allison DeAngelis The Readout LOUD The Readout LOUD How Mark Cuban plans to f up health care By Elaine Chen , Adam Feuerstein , and Allison DeAngelis The Readout LOUD The Readout LOUD Mercks heart disease win and the FDAs new drug regulator By Allison DeAngelis , Adam Feuerstein , and Elaine Chen The Readout LOUD The Readout LOUD Melodrama at the FDA and the Pfizer-Novo bidding war By Adam Feuerstein and Elaine Chen STAT Plus: Data on Humana’s clinics looked dismal.

Why This Matters

Health experts are weighing in on what this means for people.

Medical professionals are taking note of this development.

The Bottom Line

This story is still developing, and we’ll keep you updated as more info drops.

What do you think about all this?